Literature DB >> 33489395

Surgical Outcomes in Macular Telangiectasia Type 2-Related Macular Holes: A Report on Four Patients.

Kinza T Ahmad1, Joseph Chacko1, Ahmed B Sallam1, David B Warner1, Sami H Uwaydat1.   

Abstract

INTRODUCTION: The few published studies that exist on the surgical outcomes of full-thickness macular hole (FTMH) repair in Macular Telangiectasia (MacTel) Type 2 report poor rates of hole closure of around 30%. This study is the largest case series of patients with FTMH in MacTel Type 2 and describes an 80% hole closure rate.
PURPOSE: /. AIM: To describe the outcomes of four patients who underwent surgery for FTMH associated with MacTel Type 2.
METHODS: A retrospective review of clinical, surgical, and imaging data of five eyes in four patients with MacTel Type 2 FTMH who underwent pars plana vitrectomy (PPV) with internal limiting membrane (ILM) peeling and 30% SF6 or 15% C3F8 gas tamponade within 3-9 months of initial vision decline.
RESULTS: Visual acuity (VA) at the time of surgery ranged from 20/50 to 20/200. Successful hole closure was achieved in four out of five eyes, and final VA ranged from 20/20 to 20/40 at follow-up visits greater than 20 months postoperatively. The single eye that did not achieve hole closure had a final VA of 20/60.
CONCLUSION: Our case series describes higher hole closure rates and better final VA than previously published reports for macular hole surgery in patients with MacTel Type 2 FTMH.
Copyright © 2020 Kinza T. Ahmad et al.

Entities:  

Year:  2020        PMID: 33489395      PMCID: PMC7803128          DOI: 10.1155/2020/8884638

Source DB:  PubMed          Journal:  Case Rep Ophthalmol Med


  13 in total

1.  Histopathologic study of presumed parafoveal telangiectasis.

Authors:  J D Gass
Journal:  Retina       Date:  2000       Impact factor: 4.256

2.  Parafoveal telangiectasia (PFT) has been associated with changes in macular architecture and macular holes (lamellar and full thickness).

Authors:  Pukhraj Rishi; Abhishek R Kothari
Journal:  Retina       Date:  2008-01       Impact factor: 4.256

3.  Evolution and management of macular hole secondary to type 2 idiopathic macular telangiectasia.

Authors:  D Shukla
Journal:  Eye (Lond)       Date:  2011-01-21       Impact factor: 3.775

4.  INCOMPLETE REPAIR OF RETINAL STRUCTURE AFTER VITRECTOMY WITH INTERNAL LIMITING MEMBRANE PEELING.

Authors:  Toshio Hisatomi; Takashi Tachibana; Shoji Notomi; Shunji Nakatake; Kohta Fujiwara; Yusuke Murakami; Yasuhiro Ikeda; Shigeo Yoshida; Hiroshi Enaida; Toshinori Murata; Taiji Sakamoto; Koh-Hei Sonoda; Tatsuro Ishibashi
Journal:  Retina       Date:  2017-08       Impact factor: 4.256

5.  Surgery for full-thickness macular hole in patients with idiopathic macular telangiectasia type 2.

Authors:  Ninel Gregori; Harry W Flynn
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2010-07-29

6.  Parafoveal retinal telangiectasis. Light and electron microscopy studies.

Authors:  W R Green; H A Quigley; Z De la Cruz; B Cohen
Journal:  Trans Ophthalmol Soc U K       Date:  1980-04

7.  Full-thickness macular hole formation in idiopathic parafoveal telangiectasis.

Authors:  Hideki Koizumi; Jason S Slakter; Richard F Spaide
Journal:  Retina       Date:  2007 Apr-May       Impact factor: 4.256

8.  Outcomes of macular hole surgeries for macular telangiectasia type 2.

Authors:  Peter A Karth; Sharath C Raja; David M Brown; Judy E Kim
Journal:  Retina       Date:  2014-05       Impact factor: 4.256

9.  Macular full-thickness and lamellar holes in association with type 2 idiopathic macular telangiectasia.

Authors:  P Charbel Issa; H P N Scholl; A Gaudric; P Massin; A E Kreiger; S Schwartz; F G Holz
Journal:  Eye (Lond)       Date:  2008-02-08       Impact factor: 3.775

10.  Optical Coherence Tomography Angiography Findings in Type-2 Macular Telangiectasia.

Authors:  Hilal Nalcı; Figen Şermet; Sibel Demirel; Emin Özmert
Journal:  Turk J Ophthalmol       Date:  2017-10-27
View more
  1 in total

1.  Use of OCT Angiography to Diagnose and Manage Atypical Presentations of Macular Telangiectasia Type 2.

Authors:  John Moir; Shivam V Amin; Saira Khanna; Rahul Komati; Lincoln T Shaw; David Dao; Seenu M Hariprasad; Dimitra Skondra
Journal:  Int J Mol Sci       Date:  2022-07-16       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.